|
Advanced Search |
|
|
Home |
| Browse | |
|
|
Communities & Collections |
|
|
Publication Year |
|
Author |
|
|
Title |
|
|
JRC Publication N° |
|
|
Publication Type |
|
|
eBooks |
Browsing by Author SMITH R.
|
|
Showing results 1 to 2 of 2
| Publication Year | Title | Author(s), Editor(s), Other Contributor(s) | Publication Type |
|---|---|---|---|
| 2004 | MUC1 Expression in Primary and Metastatic Pancreatic Cancer Cells for in vitro Treatment by 213Bi-C595 Radioimmunoconjugate | QU Chang f.; LI Yong; SONG Yang j.; RIZVI S.m.a.; RAJA Chand; ZHANG D.; SAMRA J.; SMITH R.; PERKINS A.c.; APOSTOLIDIS Christos, et al | Articles in Journals |
| 2005 | Targeted Alpha Therapy with 213 Bi Labeled PAI2 for the Control of Micrometastatic Pancreatic Cancer. | QU Chang f.; SONG Yang j.; LI Yong; RIZVI S.m.a.; RAJA Chand; SMITH R.; MORGENSTERN A.; APOSTOLIDIS Christos; ALLEN B.j. | Articles in Journals |
Showing results 1 to 2 of 2
| The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national. |
